Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation.
Regulated on activation, normal T cell expressed, and presumably secreted (RANTES) is a member of the CC chemokine family of proteins implicated in a variety of diseases characterized by lung eosinophilia and inflammation, strongly produced by stimulated airway epithelial cells. Because such cytokines as tumor necrosis factor (TNF)-alpha and interferon-gamma (IFN-gamma) have been shown to enhance RANTES induction in airway epithelial cells and RANTES gene expression appears to be differentially regulated depending on the cell type and the stimulus applied, in this study we have elucidated mechanisms that operate to control RANTES induction on exposure to TNF-alpha and/or IFN-gamma. Our results indicate that TNF-alpha and IFN-gamma synergistically induce RANTES protein secretion and mRNA expression. RANTES transcription is activated only after stimulation with TNF-alpha, but not IFN-gamma, which affects RANTES mRNA stabilization. Promoter deletion and mutagenesis experiments indicate that the nuclear factor (NF)-kappaB site is the most important cis-regulatory element controlling TNF-induced RANTES transcription, although NF-interleukin-6 binding site, cAMP responsive element (CRE), and interferon-stimulated responsive element (ISRE) also play a significant role. TNF-alpha stimulation induces nuclear translocation of interferon regulatory factor (IRF)-3, which in viral infection binds the RANTES ISRE and is necessary for activation of RANTES transcription. However, TNF-induced IRF-3 translocation does not result in IRF-3 binding to the RANTES ISRE. Although viral infection can activate an ISRE-driven promoter, TNF cannot, indicating that RANTES gene enhancers are controlled in a stimulus-specific fashion. Identification of molecular mechanisms involved in RANTES gene expression is fundamental for developing strategies to modulate lung inflammatory responses.
Casola
Antonella
A
Departments of Pediatrics, Microbiology and Immunology, and Internal Medicine and Sealy Center for Molecular Sciences, University of Texas Medical Branch, Galveston, Texas 77555, USA. ancasola@utmb.edu
Henderson
Allyne
A
Liu
Tianshuang
T
Garofalo
Roberto P
RP
Brasier
Allan R
AR
D002478:Cells, Cultured; D018946:Chemokine CCL5 / Q000235:genetics*; D000242:Cyclic AMP / Q000502:physiology; D004847:Epithelial Cells / Q000502:physiology; D017353:Gene Deletion; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D007372:Interferons / Q000494:pharmacology; D015850:Interleukin-6 / Q000378:metabolism; D009154:Mutation / Q000502:physiology; D016328:NF-kappa B / Q000502:physiology; D011401:Promoter Regions, Genetic / Q000502:physiology*; D011650:Pulmonary Alveoli / Q000166:cytology / Q000502:physiology*; D020871:RNA Stability; D012333:RNA, Messenger / Q000378:metabolism; D020218:Response Elements / Q000187:drug effects / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D018946:Chemokine CCL5; D015850:Interleukin-6; D016328:NF-kappa B; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D007372:Interferons; D000242:Cyclic AMP